Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1993 1
1996 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN. Pappo AS, et al. Cancer. 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. Cancer. 1993. PMID: 8443761 Clinical Trial.
Based on a preclinical rhabdomyosarcoma xenograft model that accurately predicted the activity of new agents, the safety and efficacy of ifosfamide was evaluated as part of a Phase II clinical trial in previously untreated children with unresectable rhabdomyosarcoma. METHO …
Based on a preclinical rhabdomyosarcoma xenograft model that accurately predicted the activity of new agents, the safety and efficacy …
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.
Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT. Shapiro DN, et al. J Clin Oncol. 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159. J Clin Oncol. 1991. PMID: 1985166
Clinical and histopathologic features are often inadequate for accurate prediction of relapse or survival of individual patients with rhabdomyosarcoma (RMS). ...Tumor-cell ploidy was the best predictor of treatment outcome for patients with either embryonal (P less …
Clinical and histopathologic features are often inadequate for accurate prediction of relapse or survival of individual patients with …
Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.
Medary I, Aronson D, Cheung NK, Ghavimi F, Gerald W, La Quaglia MP. Medary I, et al. Ann Surg Oncol. 1996 Nov;3(6):521-5. doi: 10.1007/BF02306083. Ann Surg Oncol. 1996. PMID: 8915482
PURPOSE: The kinetics of tumor regression during administration of chemotherapy has relevance to the timing of surgery. The aim of this study was characterization of the time course of primary tumor regression in initially unresectable rhabdomyosarcoma, hepatoblastoma, and …
PURPOSE: The kinetics of tumor regression during administration of chemotherapy has relevance to the timing of surgery. The aim of this stud …
The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children.
Treuner J, Suder J, Keim M, Kaatsch P, Niethammer D. Treuner J, et al. Acta Oncol. 1989;28(1):67-72. doi: 10.3109/02841868909111184. Acta Oncol. 1989. PMID: 2706134
A multivariate analysis suggested that the response per unit of time was an important prognostic factor....
A multivariate analysis suggested that the response per unit of time was an important prognostic factor....